These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3515356)

  • 1. Immunochemical approach to detection and quantitation of DNA adducts resulting from exposure to genotoxic agents.
    Baan RA; Lohman PH; Fichtinger-Schepman AM; Muysken-Schoen MA; Ploem JS
    Prog Clin Biol Res; 1986; 207():135-46. PubMed ID: 3515356
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of monoclonal and polyclonal antibodies against DNA adducts for the detection of DNA lesions in isolated DNA and in single cells.
    Baan RA; Zaalberg OB; Fichtinger-Schepman AM; Muysken-Schoen MA; Lansbergen MJ; Lohman PH
    Environ Health Perspect; 1985 Oct; 62():81-8. PubMed ID: 3910422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrochemical detection and quantification of the acetylated and deacetylated C8-deoxyguanosine DNA adducts induced by 2-acetylaminofluorene.
    Bol SA; de Groot AJ; Tijdens RB; Meerman JH; Mullenders LH; van Zeeland AA
    Anal Biochem; 1997 Aug; 251(1):24-31. PubMed ID: 9300078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The organ-specific induction of DNA adducts in 2-acetylaminofluorene-treated rats, studied by means of a sensitive immunochemical method.
    Baan RA; Lansbergen MJ; de Bruin PA; Willems MI; Lohman PH
    Mutat Res; 1985; 150(1-2):23-32. PubMed ID: 4000159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs.
    Balansky R; Izzotti A; Scatolini L; D'Agostini F; De Flora S
    Cancer Res; 1996 Apr; 56(7):1642-7. PubMed ID: 8603414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for detection of DNA lesions induced by genotoxic agents; developments, and applications in monitoring human exposure.
    Baan RA; Fichtinger-Schepman AM; van Loon AA; van Delft JH
    Prog Clin Biol Res; 1991; 372():229-41. PubMed ID: 1956921
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases.
    Izzotti A; D'Agostini F; Bagnasco M; Scatolini L; Rovida A; Balansky RM; Cesarone CF; De Flora S
    Cancer Res; 1994 Apr; 54(7 Suppl):1994s-1998s. PubMed ID: 8137327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic turkey liver: activities of biotransformation enzymes and activation of DNA-reactive carcinogens.
    Perrone CE; Ahr HJ; Duan JD; Jeffrey AM; Schmidt U; Williams GM; Enzmann HH
    Arch Toxicol; 2004 Oct; 78(10):589-98. PubMed ID: 15167984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
    Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
    Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
    Randerath K; Randerath E; Agrawal HP; Reddy MV
    IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of carcinogen-DNA adducts by a standardized high-sensitive enzyme immunoassay.
    Kriek E; Welling M; van der Laken CJ
    IARC Sci Publ; 1984; (59):297-305. PubMed ID: 6400097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of antibodies to detect carcinogen - DNA adducts in vivo and in vitro.
    Poirier MC
    Prog Clin Biol Res; 1983; 132B():289-98. PubMed ID: 6685294
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of 1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine occurring endogenously in DNA.
    Watson WP; Aston JP; Barlow T; Crane AE; Potter D; Brown T
    IARC Sci Publ; 1999; (150):63-73. PubMed ID: 10626209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
    Farmer PB; Singh R
    Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
    Eder E; Schuler D; Budiawan
    IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA adduct detection: some applications in monitoring exposure to environmental genotoxic chemicals.
    Pfohl-Leszkowicz A; Weber-Lotfi F; Masfaraud JF; Devaux A; Laouedj A; Guillemaut P; Malaveille C; Rether B; Monod G; Dirheimer G
    IARC Sci Publ; 1993; (124):373-8. PubMed ID: 8225509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
    Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
    Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA adducts: mass spectrometry methods and future prospects.
    Farmer PB; Brown K; Tompkins E; Emms VL; Jones DJ; Singh R; Phillips DH
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):293-301. PubMed ID: 15990134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dosimetry of DNA and protein adducts in occupational health].
    Pavanello S; Clonfero E
    Med Lav; 1994; 85(5):363-9. PubMed ID: 7885291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trapping of DNA nucleotide excision repair factors by nonrepairable carcinogen adducts.
    Buterin T; Hess MT; Gunz D; Geacintov NE; Mullenders LH; Naegeli H
    Cancer Res; 2002 Aug; 62(15):4229-35. PubMed ID: 12154024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.